NASDAQ · STOCK
Incyte
$127.08
52W $71.00 – $132.60
66/100
—
16.0
0.76
Is INCY Bullish or Bearish?
Bullish.
Innellis AI committee rates Incyte (INCY) Buy with a composite score of 66/100
, based on 7 analysts with 71% agreement.
Last updated July 29, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +9.38 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -10.62 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- ROE of 29.2% shows genuine earnings power backing the valuation — Value
- EPS growing 2455.3% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock — Risk
Bear Case
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 29, 2026
Overall Committee Score
66/100
Agreement
71%
Analysts
7
Conviction
Moderate
Sector Rank
Top 0%
of 93 Healthcare peers
Value Analyst
bullish
65
/ 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 29.2% shows genuine earnings power backing the valuation
Growth Analyst
bullish
78
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 2455.3% YoY
Technical Analyst
neutral
57
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 41 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3206.65)
Investment Thesis Evolution
Committee score moved marginally from 65.6 to 65.6.
Comparing 2026-07-28 to 2026-07-29 (1 day apart).
Technical Analysis
RSI (14)
84.9
Overbought
MACD Histogram
0.395
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Bollinger %B
1.45
Above Upper Band
Price vs Moving Averages
EMA 9
$119.53
Above
EMA 21
$116.02
Above
EMA 50
$110.04
Above
EMA 200
$99.17
Above
Fundamental Analysis
Valuation
85
Growth
91
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio
16.0×
P/B Ratio
4.10×
PEG Ratio
0.20
Dividend Yield
0.00%
52W High
$132.60
52W Low
$71.00
Quality & Growth
ROE
24.9%
ROA
18.5%
Gross Margin
92.6%
Operating Margin
31.6%
Revenue Growth YoY
—
Debt / Equity
0.01
AI Fundamental Assessment
P/E ratio of 16.0 (inexpensive relative to a 15-40x range); Price-to-book of 4.1x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.2%; Net margin of 0.3%; Gross margin of 0.9%; Current ratio of 4.66 (healthy short-term liquidity); Debt-to-equity of 0.01; Free cash flow margin of 1.0% (thin cash generation); Free cash flow per share is positive (9.58); Most recent quarter beat estimates by 44.1%; 2 consecutive earnings beats; EPS growth accelerating (+0.6% -> +70.7% QoQ); Average YoY EPS growth of 96.8%; Analyst estimates rising over recent quarters
Get the Full INCY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →